Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of cefuroxime axetil solid preparation and preparation technology thereof

A technology for cefuroxime axetil and solid preparation, which can be applied in the directions of pill delivery, medical preparations without active ingredients, and medical preparations containing active ingredients, etc., and can solve problems such as great harm and safety disputes.

Active Publication Date: 2022-02-11
CHENGDU BRILLIANT PHARMA CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

On the one hand, the addition of too many excipients in the drug may also lead to safety disputes. On the other hand, because it contains hydrogenated vegetable oil, which is a mixture of saturated fatty acid triglycerides, a small amount of trans Fatty acids, generally speaking, trans fatty acids are more harmful to the human body than saturated fatty acids, and there is some controversy about their safety

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of cefuroxime axetil solid preparation and preparation technology thereof
  • A kind of cefuroxime axetil solid preparation and preparation technology thereof
  • A kind of cefuroxime axetil solid preparation and preparation technology thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] A kind of cefuroxime axetil solid preparation, the present embodiment is tablet, and tablet core formula is:

[0046]

[0047] The preparation process of the above-mentioned cefuroxime axetil tablet is the same as that of the comparative example, and glyceryl behenate is used instead of hydrogenated castor oil, and a tablet machine is used to compress it into cefuroxime axetil tablets each weighing 450 mg.

Embodiment 2

[0049]A kind of cefuroxime axetil solid preparation, the present embodiment is tablet, and tablet core formula is:

[0050]

[0051] The preparation process of the above-mentioned cefuroxime axetil tablet is the same as that of the comparative example, using sodium stearyl fumarate instead of hydrogenated castor oil, and using a tablet machine to compress into cefuroxime axetil tablets each weighing 450 mg.

Embodiment 3

[0053] A kind of cefuroxime axetil solid preparation, the present embodiment is tablet, and tablet core formula is:

[0054]

[0055] The preparation process of the above-mentioned cefuroxime axetil tablet is the same as that of the comparative example, the hydrogenated castor oil is replaced by talcum powder, and the cefuroxime axetil tablet with a weight of 450 mg is compressed by a tablet machine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a solid preparation of cefuroxime axetil, which comprises an active ingredient of a drug, cefuroxime axetil, and an auxiliary material, wherein the auxiliary material includes a lubricant, and the lubricant is selected from glyceryl behenate, sodium stearyl fumarate, and talcum powder At least one of the preservative-free. The cefuroxime axetil product of the original research company is added with preservatives such as methyl p-hydroxybenzoate, propyl p-hydroxybenzoate, sodium benzoate, and hydrogenated vegetable oil. As people pay more and more attention to the safety of food and drugs, this The safety of several preservatives and hydrogenated vegetable oils is controversial. Therefore, in order to eliminate patients' concerns about preservatives and hydrogenated vegetable oils and reduce potential safety risks, the present invention avoids the use of preservatives through research, and adopts glyceryl behenate instead of hydrogenated vegetable oils, and obtains a patent with British kudzu Cefuroxime Axetil Tablets produced by LansuSmithKline Co., Ltd. has the same bioavailability as the drug, and the drug is suitable for commercial production.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, in particular to a cefuroxime axetil solid preparation and a preparation process thereof. Background technique [0002] Cefuroxime axetil is a semi-synthetic second-generation cephalosporin drug that can be used orally and intravenously. The bactericidal activity of cefuroxime axetil in vivo comes from its parent compound cefuroxime. Cefuroxime is a well-characterized and effective antibacterial drug with a broad antibacterial spectrum and bactericidal activity against a wide range of common pathogens, including β-lactamase-producing bacteria. Cefuroxime has good stability to bacterial β-lactamases and is therefore effective against many strains resistant to ampicillin and amoxicillin. It is suitable for the treatment of infections caused by sensitive bacteria, including: lower respiratory tract infections such as acute bronchitis and acute exacerbation of chronic bronchitis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/546A61K47/14A61K47/02A61K47/12A61K9/20A61K47/38A61K9/36A61P31/04
CPCA61K31/546A61K47/14A61K47/02A61K47/12A61K9/2054A61K9/2866
Inventor 汤松彪肖碧容廖贤钟文秀赵同华何威轩
Owner CHENGDU BRILLIANT PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products